Matches in Nanopublications for { ?s ?p "[The ASPSCR1-TFE3 fusion transcript was detected in 24 of 24 alveolar soft part sarcomas (7 type 1, 17 type 2), and TFE3 immunoreactivity was observed in 22 of 24 alveolar soft part sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP754069.RA0-Vb661fzOpbIr2TJqsURDPg7zsjm7FB2pz-yzxfG5w130_assertion description "[The ASPSCR1-TFE3 fusion transcript was detected in 24 of 24 alveolar soft part sarcomas (7 type 1, 17 type 2), and TFE3 immunoreactivity was observed in 22 of 24 alveolar soft part sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754069.RA0-Vb661fzOpbIr2TJqsURDPg7zsjm7FB2pz-yzxfG5w130_provenance.
- assertion description "[The ASPSCR1-TFE3 fusion transcript was detected in 24 of 24 alveolar soft part sarcomas (7 type 1, 17 type 2), and TFE3 immunoreactivity was observed in 22 of 24 alveolar soft part sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The ASPSCR1-TFE3 fusion transcript was detected in 24 of 24 alveolar soft part sarcomas (7 type 1, 17 type 2), and TFE3 immunoreactivity was observed in 22 of 24 alveolar soft part sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP729625.RAuf9Z2uqZMvwfEZXNBisJv2qgNbIr2GyOREUG78T6Rrw130_assertion description "[The ASPSCR1-TFE3 fusion transcript was detected in 24 of 24 alveolar soft part sarcomas (7 type 1, 17 type 2), and TFE3 immunoreactivity was observed in 22 of 24 alveolar soft part sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP729625.RAuf9Z2uqZMvwfEZXNBisJv2qgNbIr2GyOREUG78T6Rrw130_provenance.
- NP916486.RAn9yXdC6qQqBKiSgbSu3AZI5CLM6v8v0iG6RemhxyvSo130_assertion description "[The ASPSCR1-TFE3 fusion transcript was detected in 24 of 24 alveolar soft part sarcomas (7 type 1, 17 type 2), and TFE3 immunoreactivity was observed in 22 of 24 alveolar soft part sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916486.RAn9yXdC6qQqBKiSgbSu3AZI5CLM6v8v0iG6RemhxyvSo130_provenance.